Argos Therapeutics, Inc. EBITDA Margin 2014-2018 | ARGSQ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Argos Therapeutics, Inc. (ARGSQ) over the last 10 years. The current EBITDA margin for Argos Therapeutics, Inc. as of September 30, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-09-30 | $0.01B | $-0.01B | -155.56% |
| 2018-06-30 | $0.01B | $-0.02B | -225.00% |
| 2018-03-31 | $0.01B | $-0.02B | -250.00% |
| 2017-12-31 | $0.00B | $-0.06B | -3100.00% |
| 2017-09-30 | $0.00B | $-0.08B | inf% |
| 2017-06-30 | $0.00B | $-0.08B | inf% |
| 2017-03-31 | $0.00B | $-0.08B | inf% |
| 2016-12-31 | $0.00B | $-0.05B | inf% |
| 2016-09-30 | $0.00B | $-0.05B | inf% |
| 2016-06-30 | $0.00B | $-0.06B | inf% |
| 2016-03-31 | $0.00B | $-0.07B | inf% |
| 2015-12-31 | $0.00B | $-0.07B | inf% |
| 2015-09-30 | $0.00B | $-0.07B | inf% |
| 2015-06-30 | $0.00B | $-0.07B | inf% |
| 2015-03-31 | $0.00B | $-0.06B | inf% |
| 2014-12-31 | $0.00B | $-0.05B | -5100.00% |
| 2014-09-30 | $0.00B | $-0.04B | -2200.00% |
| 2014-06-30 | $0.00B | $-0.04B | -1166.67% |
| 2014-03-31 | $0.00B | $-0.03B | -725.00% |
| 2013-12-31 | $0.00B | $-0.03B | -625.00% |
